Financials

News Discussions Technicals Forecast Seasonals

9969 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to INNOCARE PHARMA LTD operating, investing, and financing activities

9969 free cash flow for Q4 24 is -733.91 M HKD. For 2024, 9969 free cash flow was -336.14 M HKD and operating cash flow was -251.32 M HKD.

Q3 '18

Q4 '18

Q3 '19

Q4 '19

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: HKD

Q3 '18

Q4 '18

Q3 '19

Q4 '19

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

TTM

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—